Some individuals who are chronically infected with hepatitis B virus (HBV) eventually lose hepatitis B surface antigen (HBsAg). Hepatocellular carcinoma (HCC) has been demonstrated to occur in a few patients after loss of HBsAg. Neither factors associated with loss of HBsAg nor the incidence of HCC
Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance
β Scribed by Z.-H. Zhang; L. Li; X.-P. Zhao; D. Glebe; C. M. Bremer; Z.-M. Zhang; Y.-J. Tian; B.-J. Wang; Y. Yang; W. Gerlich; M. Roggendorf; X. Li; M. Lu; D.-L. Yang
- Book ID
- 108886467
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 384 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The aim of this study was to evaluate whether patients with chronic hepatitis delta virus (HDV) infection treated with alpha interferon and subsequent loss of hepatitis B surface antigen (HBsAg) eliminate HDV. HDV RNA was detected in 26 of 28 patients with chronic delta hepatitis using
Hepatitis B surface antigen (HBsAg) and anti-HBs antibodies (anti-HBs) may coexist in certain chronic hepatitis B (CHB) patients. This study was designed to further explore the relationship between this coexistence and hepatitis B Virus (HBV) preS deletions. Sera of 28 patients carrying both HBsAg a
## Abstract Although Korea is one of the endemic areas of hepatitis B virus (HBV) infection, the prevalence of naturally occurring variants in the major hydrophilic region (MHR) of the surface (__S__) gene of HBV has not been determined. In the present study, the prevalence of these variants was ex
## Abstract Antibody to hepatitis B surface antigen (HBsAg) (antiβHBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and antiβHBs (concurrent HBsAg/ antiβHBs) with hepatocellular carcinoma (HCC). The aim of t